CGM = continuous glucose monitoring; FIA = Formulary Impact Analyzer; PA = prior authorization.
*Individual pricing may vary depending on insurance coverage. IQVIA FIA retail data, paid sensor claims. †Patients must be enrolled in a
commercial insurance plan. Coverage may vary. ‡UnitedHealthcare has separate coverage criteria. §Individual pricing may vary depending
on insurance coverage.
1 Dexcom, data on file, 2025. 2 Dexcom, data on file, 2024. 3 Dexcom, data on file, 2023.
Dexcom and any related logos and design marks are either registered trademarks
or trademarks of Dexcom, Inc. in the United States and/or other countries.
©2025 Dexcom, Inc. All rights reserved. MAT-6915
More patients than
ever have access to
Dexcom G7 at the
pharmacy,*,†,1 now
including those
covered by
Optum Rx‡
To learn more, visit: provider.dexcom.com/pharmacists
Over 7 million commercially insured
patients with diabetes nationwide
have coverage for Dexcom G7
at the pharmacy, regardless
of treatment regimen†,§,2
• No insulin required
• No manual PA
The majority of patients pay $20 or
less per month for Dexcom CGM*,3